PDCD1 and cancer: Figure 1 presents an overview of therapies that are either state-of-the-art or otherwise routinely employed in the treatment and management of cancer, including EBRT, immunotherapy with ICI represented by PD-1/PD-L1 blockage, CCT involving taxane-based substances, and BT.